Clinical Trials on Preleukemia in Austria
Total 100 results
-
Medical University InnsbruckUniversity Hospital, Bonn; Universitätsklinikum LeipzigRecruiting
-
CelgeneCompletedMyelodysplastic Syndromes | Beta-thalassemiaAustria
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknownMyelodysplasiaAustralia
-
Otsuka Australia Pharmaceutical Pty LtdCompletedMyelodysplastic Syndrome (MDS)Australia
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeAustralia
-
GWT-TUD GmbHCelgeneRecruitingMyelodysplastic SyndromesAustria, Germany, Spain, Switzerland
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | AnemiaBelgium, Switzerland, Czech Republic, Portugal, Austria, Netherlands, Slovakia
-
European Working Group of MDS in ChildhoodUnknownMyelodysplastic Syndromes | LeukemiaGermany, Austria, Switzerland, Czech Republic, Netherlands, Denmark, Belgium, Italy, Poland
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; Groupe Francophone des Myelodysplasies; Australasian... and other collaboratorsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesAustralia, France, Germany
-
CelgeneCompletedAnemiaUnited States, Belgium, Spain, United Kingdom, Austria, Canada, Germany, Portugal, France, Australia, Israel, Japan, Italy, Czechia, Poland, Turkey
-
European Organisation for Research and Treatment...WithdrawnMyelodysplastic SyndromesFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
Sumitomo Pharma America, Inc.TerminatedMyelodysplastic Syndromes (MDS)United States
-
Agios Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesIsrael, United States, Korea, Republic of, Australia, France, Germany, Spain, United Kingdom, Czechia, Austria, Italy, Greece, Poland
-
Keros Therapeutics, Inc.RecruitingMyelodysplastic Syndromes | CytopeniaAustralia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
-
Novartis PharmaceuticalsTerminatedMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Clinical Hub for Interventional Research (CHOIR)The University of New South Wales; Australian National UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Kirby InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Cleave Therapeutics, Inc.CompletedMyelodysplastic Syndromes | Acute Myeloid Leukemia, in RelapseUnited States, Australia
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustria, Croatia
-
Peter MacCallum Cancer Centre, AustraliaUnknownMultiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid LeukaemiaAustralia
-
CelgeneCompletedMyelodysplastic SyndromesItaly, United Kingdom, Germany, Australia, Bulgaria, France, Greece, Hungary, Netherlands, Poland, Spain
-
Gilead SciencesTerminatedMyelodysplastic SyndromesUnited States, Spain, Belgium, Australia, France, Hong Kong, Hungary, Finland, New Zealand, Germany, Netherlands, United Kingdom, Italy, Switzerland, Portugal, Canada, Austria, Czechia, Norway, Poland, Turkey
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, France, Spain, Australia, Czechia, United Kingdom, Italy, Germany, Greece, Poland, Russian Federation, Bulgaria, Sweden, Netherlands, Hungary
-
Janssen Research & Development, LLCTerminatedMyelodysplastic SyndromeUnited States, Belgium, Spain, Australia, Sweden, Netherlands, Russian Federation
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, United Kingdom, Australia, Poland, Spain, Belgium, Italy, Germany, France, Canada
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesCzechia, Hungary, Japan, Taiwan, United States, Belgium, Italy, United Kingdom, Korea, Republic of, Hong Kong, Austria, Germany, Turkey, Spain, Greece, France, Canada
-
Melbourne HealthRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Plasma Cell Myeloma | Non-hodgkin Lymphoma | Leukemia, Lymphoblastic, Acute, L1 | Leukemia, Lymphoblastic, Acute, L2Australia
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
McMaster UniversitySanofi; Ozmosis Research Inc.; Cell Therapy Transplant CanadaRecruitingAcute Leukemia | Myelodysplasia | Chronic Graft-versus-host-diseaseCanada, Australia
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Active, not recruitingMyelodysplastic SyndromesUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Australia, Canada
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknownMyelodysplastic Syndromes | AdultBelgium, United States, Austria, United Kingdom, Italy, Taiwan, Brazil, China, Croatia, Czechia, France, Germany
-
NovartisCompletedMyelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare AnaemiasAustralia
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, Hungary
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada, Australia